TL-118 and Gemcitabine Drug Combination Display Therapeutic Efficacy in a MYCN Amplified Orthotopic Neuroblastoma Murine Model – Evaluation by MRI

• Chani Komar-Stossel,

  Affiliations The Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel, MRI/MRS lab HBRC, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Eitan Gross,

  Affiliation Pediatric Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Elia Dery,

  Affiliations The Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel, MRI/MRS lab HBRC, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Nathalie Corchia,

  Affiliations The Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel, MRI/MRS lab HBRC, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Karen Meir,

  Affiliation Pathology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Iris Fried,

  Affiliation Pediatric Hemato–Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Rinat Abramovitch

  * E-mail: rinat@hadassah.org.il

  Affiliations The Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel, MRI/MRS lab HBRC, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  ⨯